Researchers at the University of Osaka have developed a simple culture method that converts B cells isolated from human blood into cells resembling germinal center B cells, which refine antibodies after infection or vaccination.
New Method Enhances Antibody Production in Human Blood Cells
Researchers at the University of Osaka have developed a method to convert human blood B cells into germinal center B cells, enhancing antibody refinement. This advancement could have implications for vaccine development and public health strategies, which are relevant for Iran's healthcare system. Improved antibody production is crucial for managing infectious diseases, particularly in regions with limited resources.
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%